Epilepsy affects approximately 0.6-0.75% of dogs — management focuses on reducing seizure frequency, duration, and welfare impact through appropriate medication and monitoring.
Canine epilepsy causes welfare harm during seizures — the involuntary motor activity, apparent distress, and loss of consciousness represent acute negative experiences — and during the postictal period when dogs may be disoriented, temporarily blind, and anxious for hours. Frequent inadequately controlled seizures cause cumulative neurological harm and welfare suffering that compounds over time. Owners of epileptic dogs often experience significant distress witnessing seizures — the human welfare impact of companion animal epilepsy is underappreciated alongside the animal impact. Effective medication management achieving seizure reduction below clinically significant thresholds dramatically improves welfare — dogs with well-controlled epilepsy live largely normal lives between seizure events. The welfare goal is not merely survival but quality of life management that minimizes seizure frequency while maintaining good interical function without unacceptable medication side effects.